ENXTPA:SANPharmaceuticals
Sanofi (ENXTPA:SAN) Deepens Nuvaxovid Rollout For 2026 2027 Season
Sanofi (ENXTPA:SAN) is expanding its commercial leadership for the Nuvaxovid COVID-19 vaccine targeting the new XFG variant for the 2026-2027 season.
The rollout focuses on key markets including the U.S., European Union, and Japan, with further launches planned in Germany, Canada, and additional countries.
The Nuvaxovid agreement structure broadens commercial reach for the vaccine within Sanofi's wider vaccines portfolio and global distribution network.
The expanded Nuvaxovid XFG rollout...